Related Experiment Video
Updated: Feb 11, 2026

Isolation and Characterization of Mesenchymal Stromal Cells from Human Umbilical Cord and Fetal Placenta
Published on: April 3, 2017
REVERSAL OF FIBRONECTIN-INDUCED HIPPOCAMPAL DEGENERATION WITH ENCAPSULATED MESENCHYMAL STROMAL CELLS
Jean-Pierre Dollé1, Jeffrey Barminko1, Sai Veruva1
1Department of Biomedical Engineering Rutgers, The State University of New Jersey 599 Taylor Road, Piscataway, New Jersey 08854, USA.
Encapsulated mesenchymal stromal cells (eMSC) protected organotypic cultures from fibronectin-induced injury. These eMSC reversed OHC degradation and maintained structure, offering potential for tissue protection strategies.
Area of Science:
- Neuroscience
- Regenerative Medicine
- Cell Biology
Background:
- Mesenchymal stromal cells (MSC) exhibit tissue-protective properties by modulating inflammatory responses.
- Fibronectin accumulation is observed in pathological conditions, including central nervous system (CNS) trauma, and can harm surrounding tissues.
- Organotypic cultures provide a model to study cellular responses to injury and potential therapeutic interventions.
Purpose of the Study:
- To investigate the tissue-protective effects of encapsulated MSCs (eMSC) in an organotypic injury model.
- To assess the ability of eMSC to mitigate fibronectin-induced damage to organotypic cultures.
- To explore the role of MSC in modulating inflammatory responses and preserving tissue structure post-injury.
Main Methods:
- MSCs were encapsulated in nanoporous alginate beads to allow diffusion while maintaining cellular segregation.
- An organotypic injury model was established using fibronectin culture to induce damage.
- OHC degradation, pyramidal layer integrity, cell death, and microglial activation (IBA-1 expression) were monitored over 14 days.
Main Results:
- Fibronectin exposure led to significant OHC degradation, characterized by decreased slice area, pyramidal layer breakdown, and increased cell death.
- Microglial activation, indicated by elevated IBA-1 expression, was sustained in the presence of fibronectin.
- eMSC treatment significantly reduced OHC degradation, preserved pyramidal layer structure, decreased cell death, and promoted axonal extension.
Conclusions:
- MSCs delivered within a nanoporous alginate matrix demonstrate significant tissue-protective capabilities.
- eMSC treatment effectively reversed fibronectin-induced OHC degradation and maintained tissue integrity in an organotypic model.
- These findings suggest that encapsulated MSCs hold promise for therapeutic strategies aimed at mitigating injury-induced tissue damage.
Related Concept Videos
Fibronectins Connect Cells with ECM
Both proteoglycans and collagen are attached to fibronectin proteins, which, in turn, are attached to integrin proteins. These integrin proteins interact with transmembrane...
Mesenchymal Stem Cells
Induced Pluripotent Stem Cells
Induced Pluripotent Stem Cells
Somatic...
Reversible and Irreversible Processes
Diode: Reverse bias

